Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs041220090Completed
Open-label, single-arm trial of 5-aminolevulinic acid in breast cancer. Primary endpoints: Diagnostic odds ratio (usefulness) and Safety events related to study drug. Started Jan 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs041220090.